Arkolith/Insider Trading/PTHS/Form 4

Pauls Matthew

DirectorPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Dec 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2025Gift(G)10K—$01K
Oct 2, 2025Option exercise(M)2K—$011K
Jul 2, 2025Option exercise(M)8K—$08K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 2, 2025Option exercise(M)2K—$015K
Jul 2, 2025Option exercise(M)8K—$017K

Transaction Codes

G
Gift
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-001884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML